Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “bladder cancer”
Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT02720367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
ClinicalTrials.gov study NCT00003725. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06732531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NM
ClinicalTrials.gov study NCT05714202. IPD Sharing: YES. Countries: 21. Publications: 0.
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
ClinicalTrials.gov study NCT06287541. IPD Sharing: YES. Countries: 1. Publications: 0.
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
ClinicalTrials.gov study NCT01104350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
ClinicalTrials.gov study NCT03715660. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patterns of Urinary Bladder Cancer in Darfur, Suda
ClinicalTrials.gov study NCT06156787. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
ClinicalTrials.gov study NCT07000084. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT04073160. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04859751. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
ClinicalTrials.gov study NCT06986304. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
ClinicalTrials.gov study NCT05085977. IPD Sharing: NO. Countries: 4. Publications: 0.
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT06972771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
ClinicalTrials.gov study NCT03212651. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
ClinicalTrials.gov study NCT06662071. IPD Sharing: YES. Countries: 1. Publications: 0.
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT01458847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05223491. IPD Sharing: NO. Countries: 5. Publications: 0.
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
ClinicalTrials.gov study NCT02203136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT01314664. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.